Combined Use of Labetalol and Nifedipine in Controlling the Cardiovascular Response From ECT

Abstract

Serious cardiac complications have been reported to occur in elderly depressed patients during a course of electroconvulsive therapy (ECT). As a result, cardiac medications are being used more often to dampen the cardiovascular response that occurs during an ECT treatment. Specifically, labetalol (a mixed α- and β-blocker) has been shown to effectively control the heart rate during ECT. However, on occasion, patients may still exhibit sustained elevations of blood pressure during ECT when receiving labetalol. The optimum clinical management of these patients is unclear. The authors report on the safety and efficacy of combining nifedipine with labetalol to control blood pressure during ECT in ten elderly patients whose blood pressures were not adequately controlled by labetalol alone. No adverse effects were noted, nor did nifedipine appear to shorten seizure duration. (J Geriatr Psychiatry Neurol 1993;1:20–24).

Get full access to this article

View all access options for this article.

References

1. Figiel GS , Coffey CE , Weiner RD : Brain magnetic resonance imaging in elderly depressed patients receiving electroconvulsive therapy. Convulsive Ther 1989; 5:26–34.

2. Cattan RA , Barry PP , Mead G , et al: Electroconvulsive therapy in octogenarians. J Am Geriatr Soc 1990; 38:753–758.

3. Gerring JP , Shields HM : The identification and management of patients with a high risk for cardiac arrhythmias during modified ECT. J Clin Psychiatry 1982; 43:140–143.

4. Abrams R (ed): Electroconvulsive Therapy. Cambridge, UK, Oxford University Press, 1988, ch 5.

5. Maneksha FR : Hypertension and tachycardia during electroconvulsive therapy: To treat or not to treat?? Convulsive Ther 1991; 7:28–35.

6. Stoudemire A , Knos G , Gladson M , et al: Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry 1990; 51:508–512.

7. McCall WV , Shelp FE , Weiner RD , et al: Effects of labetalol on hemodynamics and seizure duration during ECT. Convulsive Ther 1991; 7:5–14.

8. Wells DG , Davies GG , Rosewarne F : Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine. Anaesth Intensive Care 1989; 17:31–33.

9. Jones RM : Rate pressure product. Anesthesia 1980; 35:1010–1011.

10.

10. Howie MB , Black HA , Zvara D , et al: Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg 1990; 71:384–388.

11.

11. Meyer FB , Anderson RE , Sundt TM , et al: Selective central nervous system channel blockers—a new class of anticonvulsant agents. Mayo Clin Proc 1986; 61:239–247.

12.

12. Morocutti C , Pirelli F , Savarell L , et al: Antiepileptic effects of a calcium antagonist (nimodipine) on cefazolin-induced epileptic foci in rabbits. Epilepsia 1986; 27:498–503.